Milind Ronghe - Concepedia

Author

Milind Ronghe

Also Known As

M D Ronghe, M Ronghe, M. Ronghe, M.D. Ronghe, Milind D Ronghe, Milind D. Ronghe, Milind Dattatraya Ronghe, Milind Ronghe, Robert Philips

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Royal Hospital for Children University College London Bristol Royal Hospital for Children Great Ormond Street Hospital Royal Marsden NHS Foundation Trust

About

Milind Ronghe is an author at Royal Hospital for Children specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	908
2	Health Sciences	3	3	394
3	Hepatology	2	2	384
4	Engineering	1	1	112
5	Molecular Genetics	1	1	197

Milind Ronghe

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss Penelope Brock, Rudolf Maibach, Margaret Childs, New England Journal of Medicine	2018	349
Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study József Zsíros, Laurence Brugières, Penelope Brock, The Lancet Oncology Surgical OncologyHepatologyDose-dense Cisplatin-based ChemotherapyMedicineHepatobiliary Tumor	2013	330
Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor Richard H. Scott, Jenny Douglas, Linda Baskcomb, Nature Genetics Nonsyndromic Wilms TumorDevelopmental AnomalyDevelopmental BiologySomatic VariantGenetic Disorder	2008	197
Identification of new Wilms tumour predisposition genes: an exome sequencing study Shazia Mahamdallie, Shawn Yost, Emma Poyastro-Pearson, The Lancet Child & Adolescent Health	2019	143
Stratification of Wilms tumor by genetic and epigenetic analysis Richard H. Scott, Anne R. Murray, Linda Baskcomb, Oncotarget ChromatinSomatic DefectsEngineeringSomatic VariantGenetic Disorder	2012	112
Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study) Julia Chisholm, Johannes H. M. Merks, Michela Casanova, European Journal of Cancer Adolescent PatientsMedicineMetronomic TherapyPathologyIi Study	2017	93
A genome-wide association study identifies susceptibility loci for Wilms tumor Clare Turnbull, Elizabeth R Perdeaux, David Pernet, Nature Genetics Genome-wide Association StudyGenetic AnalysisWilms TumorGeneticsPathology	2012	81
Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma – A phase II trial of the childhood liver tumour strategy group (SIOPEL) József Zsíros, Laurence Brugières, Penelope Brock, European Journal of Cancer HepatologyTumour Strategy GroupPhase Ii TrialRecurrent HepatoblastomaLiver Physiology	2012	54
The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial Thomas J. Jackson, Richard D. Williams, Jesper Brok, Pediatric Blood & Cancer	2019	51
Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low‐grade astrocytoma of the brainstem Milind Ronghe, Darren Hargrave, Ute Bartels, Pediatric Blood & Cancer	2010	41

Page 1